Population-Health Management for COPD
(EQuiP COPD Trial)
Recruiting in Palo Alto (17 mi)
+4 other locations
Age: Any Age
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Seattle Institute for Biomedical and Clinical Research
Disqualifiers: Diabetes, Hypertension, Bipolar, others
No Placebo Group
Trial Summary
What is the purpose of this trial?This trial tests whether clinical pharmacists can effectively manage COPD patients compared to pulmonary specialists. Specialists review patient records and send treatment recommendations to primary care providers electronically. The goal is to see if pharmacist-led management can achieve similar patient outcomes as specialist-led management.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. It seems that the focus is on providing recommendations to your primary care provider, who may adjust your treatment as needed.
What data supports the effectiveness of the treatment Population-health management for COPD?
Research shows that disease management programs, which include education and self-management strategies, can improve the quality and efficiency of care for COPD patients, potentially reducing hospital visits and improving quality of life.
12345How is the Population-Health Management treatment for COPD different from other treatments?
Population-Health Management for COPD is unique because it focuses on managing the disease at a community level, integrating self-management tools like eHealth platforms to improve patient outcomes and reduce hospital visits, unlike traditional treatments that may focus solely on medication or individual care.
16789Eligibility Criteria
This trial is for patients with COPD who are current smokers not on cessation aid, have had a recent exacerbation or hospital discharge due to COPD, or use inhaled corticosteroids without meeting criteria. Primary care providers at participating sites can also join.Inclusion Criteria
I was recently discharged from the hospital for a COPD flare-up.
I recently had a flare-up that required an ER or primary care visit.
I am being treated for COPD but haven't had a lung function test in 10 years or my test shows no blockage.
+5 more
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
2-4 weeks
Intervention
Population management for COPD provided by either pharmacists or pulmonary specialists through E-consults
6 months
Follow-up
Participants are monitored for safety and effectiveness after intervention
6 months
Participant Groups
The study compares population management of COPD by pharmacists versus pulmonary specialists. Both will review patient cases and provide guideline-based recommendations through E-consults for primary care providers to act upon.
2Treatment groups
Active Control
Group I: Pulmonologist ledActive Control1 Intervention
Pulmonologists will conduct population health management for patients with COPD
Group II: Pharmacist ledActive Control1 Intervention
Pharmacists will conduct population health management for patients with COPD
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Portland VA Medical CenterPortland, OR
Minneapolis VA Health Care SystemMinneapolis, MN
Ralph H. Johnson VA Medical CenterCharleston, SC
VA Puget Sound Health Care SystemSeattle, WA
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Seattle Institute for Biomedical and Clinical ResearchLead Sponsor
Patient-Centered Outcomes Research InstituteCollaborator
References
Systematic review of the effects of chronic disease management on quality-of-life in people with chronic obstructive pulmonary disease. [2019]Chronic disease management for patients with chronic obstructive pulmonary disease (COPD) may improve quality, outcomes and access to care.
Efficacy of a self-management plan in exacerbations for patients with advanced COPD. [2018]Self-management interventions improve different outcome variables in various chronic diseases. Their role in COPD has not been clearly established. We assessed the efficacy of an intervention called the self-management program on the need for hospital care due to disease exacerbation in patients with advanced COPD.
A quasi-experimental study of the effect of a comprehensive blended health educational program on self-management practices among patients with chronic obstructive pulmonary disease. [2022]The prevalence and illness burden of chronic obstructive pulmonary disease (COPD) are both high. Currently, limited guidance is available to support the establishment of effective health programs to increase self-management practices in patients with COPD.
The effect of an active implementation of a disease management programme for chronic obstructive pulmonary disease on healthcare utilization--a cluster-randomised controlled trial. [2021]The growing population living with chronic conditions calls for efficient healthcare-planning and effective care. Implementing disease-management-programmes is one option for responding to this demand. Knowledge is scarce about the effect of implementation processes and their effect on patients; only few studies have reported the effectiveness of disease-management-programmes targeting patients with chronic obstructive pulmonary disease (COPD). The objective of this paper was to determine the effect on healthcare-utilization of an active implementation model for a disease-management-programme for patients with one of the major multimorbidity diseases, COPD.
Evaluation of a disease management program for COPD using propensity matched control group. [2020]Disease management programs (DMPs) have proliferated recently as a means of improving the quality and efficiency of care for patients with chronic illness. These programs include education about disease, optimization of evidence-based medications, information and support from case managers, and institution of self-management principles. Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality in Singapore and worldwide. DMP aims to reduce mortality, hospitalizations, and average length of stay in such patients. This study assesses the outcomes of the DMP, comparing the propensity score matched DMP patients with controls.
Operating a sustainable disease management program for chronic obstructive pulmonary disease. [2019]Chronic obstructive pulmonary disease (COPD) is one of our nation's most rapidly growing chronic health conditions. It is estimated that over 16 million individuals are diagnosed with COPD (Friedman & Hilleman, 2001). In addition, another 16 million are misdiagnosed as asthma or not diagnosed at all. COPD is a condition that affects the working-age as well as the elderly. Despite the high mortality rate, COPD is a treatable and modifiable condition. Disease management programs (DMPs) for asthma are a common initiative within many health insurance plans and integrated delivery networks. Similar initiatives are not as common for COPD. This article will highlight the National Jewish Medical and Research Center's COPD DMP interventions and outcomes.
Effectiveness of chronic obstructive pulmonary disease-management programs: systematic review and meta-analysis. [2018]Disease-management programs may enhance the quality of care provided to patients with chronic diseases, such as chronic obstructive pulmonary disease (COPD). The aim of this systematic review was to assess the effectiveness of COPD disease-management programs.
Sustained effects of integrated COPD management on health status and exercise capacity in primary care patients. [2021]Chronic obstructive pulmonary disease (COPD) constitutes a growing health care problem worldwide. Integrated disease management (IDM) of mild to moderate COPD patients has been demonstrated to improve exercise capacity and health status after one year, but long-term results are currently lacking in primary care.
The Effect of Integration of Self-Management Web Platforms on Health Status in Chronic Obstructive Pulmonary Disease Management in Primary Care (e-Vita Study): Interrupted Time Series Design. [2018]Worldwide nearly 3 million people die from chronic obstructive pulmonary disease (COPD) every year. Integrated disease management (IDM) improves quality of life for COPD patients and can reduce hospitalization. Self-management of COPD through eHealth is an effective method to improve IDM and clinical outcomes.